Tirzepatide is a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) https://dawudoeql964350.ka-blogs.com/93966744/tirzepatide-a-new-frontier-in-diabetes-treatment